Schizophrenia Home > Invega Sustenna and Adolescents

Schizophrenia is a type of brain disorder that may be treated with Invega® Sustenna® (paliperidone palmitate). This prescription drug belongs to a group of medications called atypical antipsychotics. It is approved for use in adults age 18 and older; it has not been adequately studied in younger age groups.
However, there may be times when a healthcare provider may prescribe Invega Sustenna to treat schizophrenia in adolescents younger than 18 years old. This would be called an "off-label," or unapproved, use of the drug. It is important to talk to your healthcare provider about the potential risks and benefits of using this drug in children.
(For more details, click Invega Sustenna Uses. This full-length article takes a closer look at what this medication is approved for, as well as other possible off-label uses.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):



Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.